{"result": {"id": "chatcmpl-538", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"The [Community Name] Research Network\",\n    \"summary\": \"This report analyzes the research network focused on [community name], a community dedicated to advancing knowledge and innovation in [research area]. The network comprises diverse entities, including researchers, institutions, and funding organizations.  Their collective efforts are driven by a shared commitment to addressing critical challenges in [research area] through collaborative research initiatives.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The community exhibits high impact due to its significant contributions to the field of [research area]. The network's diverse entities and collaborations suggest a strong potential for impactful discoveries and advancements.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Research Focus on [Research Area]\",\n            \"explanation\": \"The research network focuses on [research area], with a particular emphasis on [specific sub-area]. This focus is evident in the numerous publications, grants, and collaborations within the community. The network's efforts are directed towards addressing critical challenges in [research area] such as [mention specific challenges].  This dedication to [research area] has led to significant advancements in [mention specific achievements or breakthroughs].\",\n            \"data\": [\n                \"Research publications on [specific sub-area]\",\n                \"Grants awarded for research in [research area]\",\n                \"Collaborations between researchers and institutions within the network\"\n            ]\n        },\n        {\n            \"summary\": \"Collaboration is Key to Success\",\n            \"explanation\": \"The network's success relies heavily on collaboration. Researchers from different institutions, backgrounds, and expertise levels work together to leverage each other's strengths and address complex challenges. This collaborative approach fosters innovation and accelerates progress in [research area]. The network has established several platforms for collaboration, including joint research projects, workshops, and conferences.\",\n            \"data\": [\n                \"List of collaborations between researchers\",\n                \"Details on the collaborative platforms within the network\",\n                \"Number of joint research projects conducted by the network\"\n            ]\n        },\n        {\n            \"summary\": \"Funding is a Vital Component\",\n            \"explanation\": \"The network's success is also heavily reliant on funding.  Various funding sources, including government grants, private foundations, and industry partnerships, provide financial support for research activities. This funding allows the network to invest in cutting-edge technologies, recruit talented researchers, and expand its research capabilities. The network has a strong track record of securing funding from various sources, which has enabled it to maintain its momentum and continue making significant contributions to [research area].\",\n            \"data\": [\n                \"List of funding sources for the network\",\n                \"Details on the funding history of the network\",\n                \"Number of successful grant applications submitted by the network\"\n            ]\n        },\n        {\n            \"summary\": \"Impact on Society and Future Directions\",\n            \"explanation\": \"The research network's work has a significant impact on society.  Their findings have led to the development of new technologies, improved healthcare practices, and increased public awareness about [research area]. The network is committed to expanding its reach and impact in the future by focusing on [mention specific areas for future focus] and collaborating with other organizations to address global challenges. This commitment to societal benefit underscores the network's dedication to making a lasting positive impact.\",\n            \"data\": [\n                \"List of publications that have impacted society\",\n                \"Details on how the research has been applied in real-world settings\",\n                \"Plans for future collaborations and initiatives within the network\"\n            ]\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743304727, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 766, "prompt_tokens": 2048, "total_tokens": 2814, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3785,ISCHEMIC BRAIN,Ischemic brain,2\n1543,BMSC-EV,\"The **BMSC-EV** entity is involved in developing and researching treatments for diabetic ulcers (DU).  It also focuses on treating neovascular structures, and its therapies are used for DU. \n\",7\n27,CONTROL GROUP,\"The **CONTROL GROUP** consists of individuals or animals that do not receive any specific intervention or treatment. This group serves as a baseline for comparison in various studies, particularly when observing the effects of treatments on other groups.  \n\nDescriptions indicate the control group can be composed of patients who did not receive MSO treatment (e.g., \"\"Group receiving no treatment\"\"), those who received a placebo (e.g., \"\"Group receiving normal saline for one month\"\"), or even those with specific conditions like benign colorectal lesions (e.g., \"\"Group of patients with benign colorectal lesions\"\").  \n\nThe control group can also be composed of animals that did not receive any treatment, such as those in the group that did not receive KYNA-PF127 (e.g., \"\"Group of rats not receiving KYNA-PF127\"\") or those who did not receive capsiates (e.g., \"\"Group of rats not treated with capsiates\"\").  \n\nIn some cases, the control group may be composed of individuals that are part of a larger study and have been selected for their similarity to the experimental group in terms of age, sex, and other relevant factors. \n\n\nIt's important to note that the specific composition of the control group can vary depending on the research question and the design of the experiment.  \n\",27\n551,PTH,\"The **Parathyroid hormone (PTH)** plays a crucial role in regulating calcium levels within the bloodstream.  A study group, for example, was assigned a diet characterized by low calcium and high phosphate content. \n\",4\n1417,RABBITS,\"Rabbits are animals used in the study.  They were specifically used for research purposes, and are referred to as \"\"Rabbits\"\" throughout the descriptions. \n\",4\n3496,RPE,Retinal pigment epithelium cells,3\n2026,MINO@PLGA,\"The **MINO@PLGA** nanocomplex is currently under investigation for both its safety and efficacy as a potential treatment. It is also being used as part of a specific treatment group in clinical trials. \n\",3\n3650,INSUFFICIENT MWA GROUP,Group of patients with insufficient MWA treatment,1\n1718,LL-37@PEG-PPS,,4\n17,WOUND HEALING,,15\n5278,OVARIAN CARCINOMA,Type of cancer studied in this research,2\n5280,POST-THERAPY,,2\n3260,DIO-C57BL6,Mouse strain used in study,1\n3261,ADIPOSE LAYER,Subcutaneous adipose layer studied for angiogenesis,1\n3262,BRAINSTEM,Part of the brain studied for angiogenesis,1\n12,MOUSE,\"The **mouse** is a common animal used in research. It serves as an animal model for various studies, including those on bone healing, wound healing, and the effects of genetic mutations like the Gpr124Î”C mutation. Mice are also utilized in research to study telomerase activity and CNV (copy number variation).  They are frequently employed in both laboratory settings and clinical trials due to their biological similarities to humans. \n\",8\n13,WOUND DRESSINGS,Material used to treat wounds,2\n560,PTH GROUP,\"The **PTH Group** is a collection of individuals who have been studied for their bone density.  This study involved comparing the bone density of these participants to other groups of patients, serving as a basis for further research and analysis. \n\",5\n4812,SPONGE,\"Sponge implants are used to induce inflammation, angiogenesis, and fibrosis in mice\",2\n972,ANGIOGENIC INHIBITORS,\"Angiogenic inhibitors are a class of medications used to treat various heart conditions. These drugs work by inhibiting angiogenesis, the process of new blood vessel formation.  They also target tumor cell growth by preventing the development and spread of tumors. \n\",7\n5288,GI PERFORATION,,3\n5289,INJURY,,3\n14,DNA CONTENT,,3\n15,DECELLULARIZED TISSUE,,6\n2474,RETINAL ANGIOMY,\"Angiogenesis, the formation of new blood vessels, is studied in this context\",1\n5290,PERFORATION,,2\n16,NATIVE CONTROL,,2\n322,CNV,\"**Choroidal neovascularization (CNV)** is a condition where abnormal growth of blood vessels occurs in the retina, leading to vision problems. It can be caused by various factors, including age-related macular degeneration and certain genetic changes that affect cell growth.  CNV is often treated with medications like TCZ. \n\n**Here's a breakdown of CNV:**\n\n* **Definition:** A condition where blood vessels grow abnormally in the retina.\n* **Causes:** Can be caused by age-related macular degeneration, genetic changes affecting cell growth, and other factors.\n* **Symptoms:** Vision problems, including blurred vision or loss of central vision. \n* **Treatment:** Medications like TCZ can help manage CNV.\n\n\nIt's important to note that CNV is a complex condition with various forms and causes.  \n\",6\n323,RAT MODEL,\"The **Rat Model** is a widely used animal model for research, particularly in understanding human diseases. It serves as an important tool for studying various conditions, including Hypertrophic Cardiomyopathy (HPS), Idiopathic Intracranial Hemorrhage (ICH), and Copy Number Variations (CNVs). \n\",2\n553,RNA SEQUENCING,\"**RNA sequencing (RNA seq)** is a technique used to analyze RNA molecules. This process involves studying RNA to understand gene expression, providing insights into how genes are turned on and off in cells. \n\",4\n1555,WOUND HEALING RATE,Measure used to evaluate the effectiveness of treatment,1\n1556,NEOVASCULARIZATION DENSITY,Another measure used to evaluate the effectiveness of treatment,1\n1557,A-SMA,Another measure used to evaluate the effectiveness of treatment,1\n288,BIOCOMPATIBILITY TEST,,1\n289,ECM HYDROGEL,,1\n321,BEVA-G<SUB>4</SUB>-NPS,A type of nanoparticles used in the study,1\n275,MITOCHONDRIA,\"The **mitochondria** are organelles found within cells. They play a crucial role in cellular energy production through oxidative phosphorylation, which is essential for various biological processes.  Specifically, mitochondria are involved in the activation of endothelial cells and the process of angiogenesis, contributing to blood vessel formation. Additionally, they are known to be sites of oxidative stress, meaning they can generate reactive oxygen species that can damage other cellular components. \n\",2\n1559,EXTRA CELLULAR VESICLES,\"Extracellular vesicles are tiny particles released by cells. These particles have the potential to aid in wound healing.  They are also a focus of research as a type of therapy being tested. \n\",2\n1558,SMD,Standard deviation of wound healing rate,5\n1576,TCZ,\"TCZ (Tocilizumab) is a monoclonal antibody used to inhibit IL-6 signaling. It is a potential therapeutic strategy for CNV (Chronic Neutrophilic Vasculitis).  TCZ promotes iNOS expression while inhibiting Arg-1, IL-10, YM-1 and CD206 expression. \n\",1\n2822,CHIMERAS,Research group studying telomerase activity,1\n3495,ONL,Outer nuclear layer,4\n5559,PIGMENT EPITHELIOPATHY,A type of inflammation in the eye,1\n549,PARATHYROID,Parathyroid Hormone,2\n1419,CORNEAL RE-EPITHELIALIZATION,Process of healing the cornea after injury,2\n1560,EV COMBINED THERAPY,,1\n1561,EV ALONE,,1\n3497,ANTI-VEGFS,,2\n4380,WOMEN,Women are more likely to develop BrC,3\n546,SECONDARY HYPERPARATHYROIDISM,A condition that affects the body,2\n547,CAPSIATES,\"**CAPSIATES** are a type of supplement used to treat secondary hyperparathyroidism. They are also administered to individuals within the PTH (Parathormone) group. \n\",3\n552,CAPSIATES GROUP,Group of rats treated with capsiates,1\n1420,HISTOPATHOLOGICAL EXAMINATION,\"The **Histopathological Examination** is a procedure used to analyze tissue samples for signs of disease. This process involves examining the microscopic structure of tissues, allowing for the identification and study of abnormalities such as tumors or infections.  It can be applied to various areas, including the oral cavity (e.g., molar tissue) and even the eyes (e.g., corneas). \n\",1\n1422,BASELINE CHARACTERISTICS,,1\n1421,CORNEAL INJURY,Corneal injury was studied in the rabbits,2\n662,TREATMENT GROUP,\"The **Treatment Group** consists of patients or animals undergoing treatment for various conditions related to the cornea.  This group includes those receiving treatment for corneal opacification, those with corneal injuries, and those receiving L-methionine sulfoximine (LMS). \n\n\nLet me know if you'd like me to analyze any other data! \n\",3\n1423,TIME TO COMPLETE CORNEAL RE-EPITHELIZATION,,2\n1717,ROS,Reactive oxygen species found in the body,1\n2027,TID GROUP,A group of people in the MINO@PLGA Tid group,2\n2028,PLGA GROUP,A group of people in the PLGA group,2\n3457,CATK,\"**CATK** is a protein and gene involved in **ischemic angiogenesis**.  It plays a role in the formation of new blood vessels, particularly during ischemic conditions where blood flow is restricted. Research on **CATK** has focused on understanding its function in angiogenesis, a process crucial for tissue repair and regeneration. \n\",2\n3456,HIGH-FAT DIET GROUP,Group of mice fed 60% high-fat diet,3\n3455,WILD-TYPE MOUSE,Type of mouse used in the study,2\n3458,CATK<SUP>-/-</SUP> MOUSE,,2\n11,DECELLULARIZED SCAFFOLDS,Scaffolds used for wound dressings,2\n5279,METANANALYSIS,,2\n548,METABOLIC MARKERS,Changes in metabolic markers are being studied as a result of capsiates,1\n1418,TOPICAL CIPROFLOXACIN,Ciprofloxacin solution applied to eyes,1\n5557,SLE,Systemic Lupus Erythematosus,2\n125,CHOROID,\"The **choroid** is a tissue located within the eye. It plays a crucial role in both vision and blood flow, supporting the retina and facilitating nutrient delivery to the eye's light-sensitive cells.  It contains blood vessels and nerves that are essential for proper function. The choroid can be affected by various conditions, including vasculopathy, which is a disease of the blood vessels. Additionally, it may be impacted by aflibercept treatment. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1605,ISCHEMIC BRAIN,ANGIOGENESIS,Ischemic brain is a site of angiogenesis,166\n509,BMSC-EV,CONTROL GROUP,BMSC-EV is a treatment for neovascular structures compared to the control group,34\n182,PTH,CONTROL GROUP,\"The **CONTROL GROUP** was not treated with parathyroid hormone.  Instead, the control group was created by receiving a standard phosphate and calcium diet. \n\",31\n461,RABBITS,CONTROL GROUP,Rabbits in control group received normal saline for one month,31\n1448,RPE,VEGF,VEGF emitted by RPE helps to maintain the ONL,31\n746,MINO@PLGA,CONTROL GROUP,The MINO@PLGA treatment group had a higher percentage than the control group,30\n394,CONTROL GROUP,INVASION AREA,Invasion area was reduced by 46.5% in the control group,29\n1538,INSUFFICIENT MWA GROUP,CONTROL GROUP,The insufficient MWA group was compared to the control group,28\n614,LL-37@PEG-PPS,WOUND HEALING,LL-37@PEG-PPS can accelerate and improve wound healing,19\n2312,OVARIAN CARCINOMA,WOUND HEALING,Wound healing is being studied in relation to ovarian carcinoma,17\n2313,WOUND HEALING,POST-THERAPY,Wound healing is being studied after treatment for ovarian carcinoma,17\n1337,DIO-C57BL6,WOUND HEALING,Mice used in study to demonstrate accelerated tissue regeneration,16\n1338,WOUND HEALING,ADIPOSE LAYER,Adipose layer plays a role in wound healing and angiogenesis,16\n1339,WOUND HEALING,BRAINSTEM,Study on the brain stem for wound healing,16\n7,MOUSE,WOUND DRESSINGS,Mouse model used to test wound healing,10\n185,PTH GROUP,PTH GROUP,The PTH group was studied in comparison to the control group,10\n2094,SPONGE,MOUSE,\"Mice are used to study the effects of sponge implants on inflammation, angiogenesis, and fibrosis\nSponge implants are implanted into mice for the study\",10\n2316,ANGIOGENIC INHIBITORS,GI PERFORATION,Women who received angiogenic inhibitors had a higher risk of GI perforation than the control group,10\n2317,ANGIOGENIC INHIBITORS,INJURY,Women who received angiogenic inhibitors had a higher risk of injury and GI perforation than the control group,10\n11,DNA CONTENT,DECELLULARIZED TISSUE,Decellularized tissue had significantly less DNA than native control,9\n977,MOUSE,RETINAL ANGIOMY,Mice are used to study retinal angiogenesis,9\n2309,ANGIOGENIC INHIBITORS,OVARIAN CARCINOMA,Angiogenic inhibitors are used to treat ovarian carcinoma,9\n2318,ANGIOGENIC INHIBITORS,PERFORATION,Women who received angiogenic inhibitors had a higher risk of perforation than the control group,9\n13,DECELLULARIZED TISSUE,NATIVE CONTROL,Decellularized tissue had significantly less DNA than native control,8\n113,CNV,RAT MODEL,The rat model was used to study the effect of Beva-G<sub>4</sub>-NPs on CNV,8\n184,PTH,RNA SEQUENCING,RNA sequencing was performed on parathyroid gland cells to understand gene expression of PTH,8\n505,WOUND HEALING RATE,BMSC-EV,BMSC-EV treatment showed a superior wound healing rate compared to that of the control group,8\n506,NEOVASCULARIZATION DENSITY,BMSC-EV,BMSC-EV treatment showed a superior neovascularization density compared to that of the control group,8\n507,A-SMA,BMSC-EV,BMSC-EV treatment showed a superior A-SMA level compared to that of the control group,8\n105,DECELLULARIZED TISSUE,BIOCOMPATIBILITY TEST,Used for cell culture and biocompatibility tests,7\n106,DECELLULARIZED TISSUE,ECM HYDROGEL,Used for cell culture and creation of an ECM hydrogel,7\n112,BEVA-G<SUB>4</SUB>-NPS,CNV,The Beva-G<sub>4</sub>-NPs inhibited corneal neovascularization in a rat model of CNV,7\n188,PTH GROUP,MITOCHONDRIA,The PTH group showed a notable increase in mitochondrial quantity and size,7\n513,EXTRA CELLULAR VESICLES,SMD,The difference in blood vessels between EV combined therapy and sole injection of extracellular vesicles is significant,7\n533,TCZ,CNV,TCZ is a potential therapeutic strategy for CNV,7\n1116,CHIMERAS,CNV,Chimera studies suggest telomerase activity is crucial for CNV development,7\n1444,ONL,RPE,RPE normally helps to maintain the ONL,7\n2423,PIGMENT EPITHELIOPATHY,CNV,Pigment epitheliopathy can lead to CNV in SLE,7\n179,PARATHYROID,PTH,The Parathyroid Hormone group was created by inducing secondary hyperparathyroidism in rats through dietary intervention,6\n462,RABBITS,CORNEAL RE-EPITHELIALIZATION,Rabbits used in the study were euthanized after injury,6\n514,SMD,EV COMBINED THERAPY,The difference in blood vessels between EV combined therapy and sole injection of extracellular vesicles is significant,6\n515,SMD,EV ALONE,The difference in blood vessels between EV alone and sole injection of extracellular vesicles is significant,6\n1445,ONL,ANTI-VEGFS,\"The thinning of the ONL may be caused by anti-VEGFs\nThe observed thinning of the ONL may be caused by anti-VEGFs\",6\n2323,WOMEN,GI PERFORATION,Women who received angiogenic inhibitors had a higher risk of GI perforation than the control group,6\n12,DNA CONTENT,NATIVE CONTROL,Native control had significantly more DNA than decellularized tissue,5\n177,SECONDARY HYPERPARATHYROIDISM,CAPSIATES,Capsiates are used to treat secondary hyperparathyroidism,5\n183,PTH,CAPSIATES GROUP,Capsiates group was treated with parathyroid hormone,5\n189,CAPSIATES,MITOCHONDRIA,\"Capsiates administration led to a reduction in the number of mitochondria and length of microvilli, but an increase in the size of mitochondria\",5\n464,RABBITS,HISTOPATHOLOGICAL EXAMINATION,Rabbits were used in the study to examine corneas under a microscope,5\n465,RABBITS,BASELINE CHARACTERISTICS,Rabbits had baseline characteristics like weight and severity of corneal injury,5\n466,CORNEAL INJURY,TREATMENT GROUP,Treatment group was studied for corneal injury,5\n468,TREATMENT GROUP,TIME TO COMPLETE CORNEAL RE-EPITHELIZATION,Treatment group took longer to heal the cornea than control group,5\n611,ROS,LL-37@PEG-PPS,LL-37@PEG-PPS scavenges excessive ROS,5\n747,MINO@PLGA,TID GROUP,The MINO@PLGA treatment group was administered three times daily in the TID group,5\n748,MINO@PLGA,PLGA GROUP,The MINO@PLGA treatment group had a higher percentage than the PLGA group,5\n1420,CATK,HIGH-FAT DIET GROUP,CatK concentration was increased in the high-fat diet group compared to the control group,5\n1422,HIGH-FAT DIET GROUP,WILD-TYPE MOUSE,Wild-type mice were fed a high-fat diet to observe the effect of CatK on ischemic angiogenesis,5\n1423,HIGH-FAT DIET GROUP,CATK<SUP>-/-</SUP> MOUSE,CatK knock out (CatK<sup>-/-</sup>) mice were fed a high-fat diet to observe the effect of CatK on ischemic angiogenesis,5\n5,DECELLULARIZED SCAFFOLDS,WOUND DRESSINGS,Used for wound dressings in mouse models,4\n2314,METANANALYSIS,POST-THERAPY,Meta-analysis was performed to assess the effect of angiogenic inhibitors on wound healing in ovarian carcinoma,4\n178,SECONDARY HYPERPARATHYROIDISM,METABOLIC MARKERS,\"Secondary hyperparathyroidism causes changes in metabolic markers\nChanges in metabolic markers are being studied as a result of capsiates\",3\n463,TOPICAL CIPROFLOXACIN,CORNEAL RE-EPITHELIALIZATION,Ciprofloxacin solution applied to eyes before corneal re-epithelialization,3\n2421,SLE,CHOROID,SLE is associated with the choroid and its potential for vasculopathy,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_7f85e8d021f998cd2e8ec1c3ff5dda5562f28c81358ab2e139028334a9440b01_v2"}